Erythropoietin News and Research

RSS
Erythropoietin, or its alternative erythropoetin or EPO, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow.
60 years in the making: Nanoparticles revolutionize nucleotide delivery

60 years in the making: Nanoparticles revolutionize nucleotide delivery

Researchers leverage machine-learning techniques to predict future risk of pressure injuries

Researchers leverage machine-learning techniques to predict future risk of pressure injuries

New custom-designed proteins can efficiently reach intramembrane targets

New custom-designed proteins can efficiently reach intramembrane targets

Using near-infrared spectroscopy to study how infant brains respond to touch

Using near-infrared spectroscopy to study how infant brains respond to touch

New implantable device carries insulin-producing islet cells to control diabetes

New implantable device carries insulin-producing islet cells to control diabetes

Riboswitch may be the key to advance gene therapy, regenerative medicine

Riboswitch may be the key to advance gene therapy, regenerative medicine

Circulating microparticle proteins predict placenta accreta spectrum before delivery

Circulating microparticle proteins predict placenta accreta spectrum before delivery

Scientists show how cellular hypoxia response increases fetal hemoglobin expression in adults

Scientists show how cellular hypoxia response increases fetal hemoglobin expression in adults

Adding erythropoietin to cooling therapy shows no added benefits for newborns with birth asphyxia

Adding erythropoietin to cooling therapy shows no added benefits for newborns with birth asphyxia

New regulatory code of protein glycosylation

New regulatory code of protein glycosylation

Kyoto scientists reveal characteristic behaviors of erythropoietin-producing cells

Kyoto scientists reveal characteristic behaviors of erythropoietin-producing cells

Oral drug works just as well as conventional therapy for anemia in patients with kidney disease

Oral drug works just as well as conventional therapy for anemia in patients with kidney disease

Results of high-impact clinical trials could affect kidney-related medical care

Results of high-impact clinical trials could affect kidney-related medical care

Oral drug found to be effective, safe for treating anemia in patients with chronic kidney disease

Oral drug found to be effective, safe for treating anemia in patients with chronic kidney disease

Latin American and Caribbean research contributions to tackle challenges posed by brain diseases

Latin American and Caribbean research contributions to tackle challenges posed by brain diseases

Study reveals mechanisms by which SGLT2 inhibitors produce renoprotective effect

Study reveals mechanisms by which SGLT2 inhibitors produce renoprotective effect

Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure

Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure

High altitude experts explain pneumolysis caused by COVID-19

High altitude experts explain pneumolysis caused by COVID-19

Cell survival protein could protect kidneys from damage caused by cancer therapies

Cell survival protein could protect kidneys from damage caused by cancer therapies

Scientists identify key driver in BRAF inhibitor resistant melanoma

Scientists identify key driver in BRAF inhibitor resistant melanoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.